Literature DB >> 12598066

Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system.

Philip B Adamson1, Anthony Magalski, Frieder Braunschweig, Michael Böhm, Dwight Reynolds, David Steinhaus, Allyson Luby, Cecilia Linde, Lars Ryden, Bodo Cremers, Teri Takle, Tom Bennett.   

Abstract

OBJECTIVES: This study examined the characteristics of continuously measured right ventricular (RV) hemodynamic information derived from an implantable hemodynamic monitor (IHM) in heart failure patients.
BACKGROUND: Hemodynamic monitoring might improve the day-to-day management of patients with chronic heart failure (CHF). Little is known about the characteristics of long-term hemodynamic information in patients with CHF or how such information relates to meaningful clinical events.
METHODS: Thirty-two patients with CHF received a permanent RV IHM system similar to a single-lead pacemaker. Right ventricular systolic and diastolic pressures, heart rate, and pressure derivatives were continuously measured for nine months without using the data for clinical decision-making or management of patients. Data were then made available to clinical providers, and the patients were followed up for 17 months. Pressure characteristics during optimal volume, clinically determined volume-overload exacerbations, and volume depletion events were examined. The effect of IHM on hospitalizations was examined using the patients' historical controls.
RESULTS: Long-term RV pressure measurements had either marked variability or minimal time-related changes. During 36 volume-overload events, RV systolic pressures increased by 25 +/- 4% (p < 0.05) and heart rate increased by 11 +/- 2% (p < 0.05). Pressure increases occurred in 9 of 12 events 4 +/- 2 days before the exacerbations requiring hospitalization. Hospitalizations before using IHM data for clinical management averaged 1.08 per patient year and decreased to 0.47 per patient-year (57% reduction, p < 0.01) after hemodynamic data were used.
CONCLUSIONS: Long-term ambulatory pressure measurements from an IHM may be helpful in guiding day-to-day clinical management, with a potentially favorable impact on CHF hospitalizations.

Entities:  

Mesh:

Year:  2003        PMID: 12598066     DOI: 10.1016/s0735-1097(02)02896-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  73 in total

1.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

2.  Left ventricular epicardial admittance measurement for detection of acute LV dilation.

Authors:  John E Porterfield; Erik R Larson; James T Jenkins; Daniel Escobedo; Jonathan W Valvano; John A Pearce; Marc D Feldman
Journal:  J Appl Physiol (1985)       Date:  2010-12-09

3.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

4.  Remote heart failure monitoring.

Authors:  William T Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 5.  Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.

Authors:  Jeffrey Wing-Hong Fung; Cheuk-Man Yu
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 6.  The vulnerable phase after hospitalization for heart failure.

Authors:  Stephen J Greene; Gregg C Fonarow; Muthiah Vaduganathan; Sadiya S Khan; Javed Butler; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

7.  A Novel Wireless Left Atrial Pressure Monitoring System for Patients with Heart Failure, First Ex-Vivo and Animal Experience.

Authors:  Leor Perl; Elina Soifer; Jozef Bartunek; Dedi Erdheim; Friedrich Köhler; William T Abraham; David Meerkin
Journal:  J Cardiovasc Transl Res       Date:  2019-01-02       Impact factor: 4.132

Review 8.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

9.  Cardiac Resynchronization Therapy for Advanced Heart Failure.

Authors:  Philip B. Adamson; William T. Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

Review 10.  Implantable devices to monitor patients with heart failure.

Authors:  Nikolaos Karamichalakis; John Parissis; George Bakosis; Vasiliki Bistola; Ignatios Ikonomidis; Antonios Sideris; Gerasimos Filippatos
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.